1. Sarcoma of vulva, vagina and ovary
- Author
-
Pierre Auberdiac, Cyrus Chargari, Nicolas Magné, Christine Haie Meder, Yacine Merrouche, Céline Chauleur, Cécile Pacaut, and Jean-Philippe Jacquin
- Subjects
Ovarian Neoplasms ,Oncology ,medicine.medical_specialty ,Vaginal Neoplasms ,Vulvar Neoplasms ,Medical treatment ,business.industry ,Vulva vagina ,Obstetrics and Gynecology ,Sarcoma ,Ovary ,Signs and symptoms ,General Medicine ,medicine.disease ,Dermatology ,medicine.anatomical_structure ,Quality of life ,Internal medicine ,medicine ,Adjuvant therapy ,Humans ,Ovarian Sarcoma ,Female ,business - Abstract
Less than 5% of vulvar, vaginal and ovarian malignant diseases are sarcomas. Adequate knowledge of these particular malignant diseases is essential for accurate diagnosis and for choice of surgical treatment, adjuvant therapy and efficient medical treatment in relapse. A crucial aspect in the management of women with these diseases is a multidisciplinary approach. Globally, presenting signs and symptoms of these sarcomas are non-specific of histological type but linked to initial location. In view of this, management should be undertaken by clinicians experienced in these particular malignancies. Long-term side-effects, particularly in children with sarcoma, adversely affect quality of life. New treatment strategies require special attention.
- Published
- 2011
- Full Text
- View/download PDF